Douglas Krakower, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Gilead
    Topic:
    HIV
    Date added:
    01/20/2026
    Date updated:
    01/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    HIV
    Date added:
    01/20/2026
    Date updated:
    01/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Travel
    Ineligible company:
    PrEP4All
    Topic:
    HIV
    Date added:
    01/20/2026
    Date updated:
    01/20/2026
    Relationship end date:
    02/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Uptodate
    Topic:
    HIV
    Date added:
    01/20/2026
    Date updated:
    01/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Other Business Ownership
    Ineligible company:
    Quilt Health
    Topic:
    Health care delivery
    Date added:
    01/20/2026
    Date updated:
    01/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Other Business Ownership
    Ineligible company:
    FluidForm Bio
    Topic:
    Tissue generation
    Date added:
    01/20/2026
    Date updated:
    01/20/2026
Return to 225 HIV Lecture Session “Machine Learning & HIV" (012126)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.